The US Food and Drug Administration today approved Xofigo (radium Ra 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones but not to other organs.

The US Food and Drug Administration approved the production and use of Choline C 11 Injection, a positron emission tomography (PET) imaging agent used to help detect recurrent prostate cancer.

The U.S. Food and Drug Administration is warning consumers about a potentially harmful product represented as “ExtenZe ,” a dietary supplement for male sexual enhancement. The counterfeit product looks similar to the actual product, but contains hidden ingredients that can cause serious harm to consumers.

USA Far Ocean Group Inc. announced that it is conducting a voluntary nationwide recall of the Company's supplement product sold under the name “U-Prosta Natural support for prostate health”.

Biotab Nutraceuticals , Inc. ( “Biotab” ) is conducting a voluntary recall of two lots of EXTENZE nutritional supplement tablets.

Kanec USA Inc. is voluntarily recalling all lots of its male enhancement capsules due to unapproved use of an erectile dysfunction drug that could lead to potentially dangerous drug interactions.